Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › CMS Expands Coverage of SARS-CoV-2 Testing for Medicare, Medicaid Beneficiaries

CMS Expands Coverage of SARS-CoV-2 Testing for Medicare, Medicaid Beneficiaries

Apr 30, 2020
|
staff reporter

NEW YORK – The US Centers for Medicare & Medicaid Services on Thursday announced regulatory waivers to expand coverage of SARS-CoV-2 testing to seniors and Medicaid recipients as part of a broad range of changes to ease rules and provide relief to the healthcare system during the coronavirus pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Cleveland Clinic, Three Other Labs Get FDA EUAs for Coronavirus Tests

  2. Siemens Gets First Authorizations for Tests That Estimate Quantities of SARS-CoV-2 Antibodies

  3. Roche Epstein-Barr Virus Quantitative Test Receives FDA Clearance

  4. FDA Grants Emergency Use Authorizations for Zeesan Biotech, UCSD Coronavirus Tests

  5. Quest Receives FDA EUA for Faster Viral RNA Extraction Method

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.